Tuesday, May 22, 2018

Latest:

New therapy for pediatric brain tumors could reduce long-term cognitive issues
Surviving bladder cancer: One year later and going strong
This is what the Warburg pathway can do for breast cancer growth
Throwback Thursday: Vacation Plans
Medical care: More than just the doctor and patient

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
GoWoman
bcm.edu

lysosome

USP15 could be a target in ovarian cancer scientists have been looking for

May 8, 2018May 8, 2018 Ana Rodríguez 0 Comments lysosome, ovarian cancer, ovarian steroids, p53, p53-R175H, proteasome, Research, steroid receptor coactivator, USP 15

Ovarian cancer is currently treated with surgery and chemotherapy. Chemotherapy for ovarian cancer is based on drugs that act on

Read more

From The Labs Image of the Month

From The Labs features differences in a mouse model of spinocerebellar ataxia type 1, a rare autosomal dominant disorder. Read More.

Relive Match Day 2018 at Baylor

Soccer Champion Carli Lloyd is Empowering Healthcare Decisions

Archives

Archives

Search

©1998 - 2018 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951